The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
出版年份 2020 全文链接
标题
The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-03
DOI
10.1007/s00259-019-04673-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition
- (2019) Tobias Hofving et al. ENDOCRINE-RELATED CANCER
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
- (2017) Bryan Oronsky et al. NEOPLASIA
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
- (2017) et al. Cancers
- Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
- (2015) Diana Spiegelberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET
- (2015) Annarita Ianniello et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors
- (2015) Khanh Do et al. INVESTIGATIONAL NEW DRUGS
- Carcinoid and Neuroendocrine Tumors: Building on Success
- (2015) Pamela L. Kunz JOURNAL OF CLINICAL ONCOLOGY
- The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells
- (2015) Diana Spiegelberg et al. Oncotarget
- First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors
- (2014) G. I. Shapiro et al. CLINICAL CANCER RESEARCH
- Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
- (2013) KATHRIN ZITZMANN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions
- (2012) David S. Hong et al. CANCER TREATMENT REVIEWS
- Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors
- (2012) Michael H�pfner INTERNATIONAL JOURNAL OF ONCOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Molecular Markers for Novel Therapeutic Strategies in Pancreatic Endocrine Tumors
- (2012) Judith A. Gilbert et al. PANCREAS
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
- (2011) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Biodistribution of 177Lu-octreotate and 111In-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT2
- (2011) Johanna Dalmo ONCOLOGY REPORTS
- Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors
- (2010) Judith A Gilbert et al. ENDOCRINE-RELATED CANCER
- Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
- (2010) E. Vegt et al. JOURNAL OF NUCLEAR MEDICINE
- Heat Shock Protein 90: Inhibitors in Clinical Trials
- (2009) Marco A. Biamonte et al. JOURNAL OF MEDICINAL CHEMISTRY
- A comparative study of 131I and 177Lu labeled somatostatin analogues for therapy of neuroendocrine tumours
- (2008) E.B. de Araújo et al. APPLIED RADIATION AND ISOTOPES
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now